drugset / Trial / NCT00235053

Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID

NCT00235053

Phase 4 Completed 13 enrolled Allergy & Asthma Medical Group & Research Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This Pilot study is designed to explore the rate of local side effects of fluticasone as delivered by Advair and to determine the best outcome measure to assess these effects. This study is the initial step, and will be followed by a larger scale study.

Timeline

Start
2005-08
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 250 ug Inhaled
Background Salmeterol Other / unclassified 50 ug